Publicaciones en las que colabora con Pedro Sánchez Rovira (15)

2022

  1. Type 2 Diabetes-Related Variants Influence the Risk of Developing Prostate Cancer: A Population-Based Case-Control Study and Meta-Analysis

    Cancers, Vol. 14, Núm. 10

2020

  1. Drug repurposing for triple-negative breast cancer

    Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-34

2019

  1. Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathways

    European Journal of Nutrition, Vol. 58, Núm. 8, pp. 3207-3219

2018

  1. Activating transcription factor 4 modulates TGFb-induced aggressiveness in triple-negative breast cancer via SMad2/3/4 and mTORC2 signaling

    Clinical Cancer Research, Vol. 24, Núm. 22, pp. 5697-5709

2014

  1. EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer

    Oncotarget, Vol. 5, Núm. 17, pp. 7486-7497

2013

  1. CD133 expression in circulating tumor cells from breast cancer patients: Potential role in resistance to chemotherapy

    International Journal of Cancer, Vol. 133, Núm. 10, pp. 2398-2407

  2. Impact of Diet on Breast Cancer Risk: A Review of Experimental and Observational Studies

    Critical Reviews in Food Science and Nutrition, Vol. 53, Núm. 1, pp. 49-75

  3. Transcriptional Shift Identifies a Set of Genes Driving Breast Cancer Chemoresistance

    PLoS ONE, Vol. 8, Núm. 1

2012

  1. Biomarkers characterization of circulating tumour cells in breast cancer patients

    Breast Cancer Research, Vol. 14, Núm. 3

  2. Oxidative stress status in metastatic breast cancer patients receiving palliative chemotherapy and its impact on survival rates

    Free Radical Research, Vol. 46, Núm. 1, pp. 2-10

2011

  1. Circulating cancer cells in division in an early breast cancer patient

    Annals of Oncology

  2. Does chemotherapy-induced oxidative stress improve the survival rates of breast cancer patients?

    Antioxidants and Redox Signaling, Vol. 15, Núm. 4, pp. 903-909

  3. Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. Biological bases to develop oxidative-based therapies

    Critical Reviews in Oncology/Hematology, Vol. 80, Núm. 3, pp. 347-368

2010

  1. Gene-expression profiles, tumor microenvironment, and cancer stem cells in breast cancer: Latest advances towards an integrated approach

    Cancer Treatment Reviews, Vol. 36, Núm. 6, pp. 477-484

2009

  1. Clinical relevance associated to the analysis of circulating tumour cells in patients with solid tumours

    Clinical and Translational Oncology